Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026)
Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 0.50% |
| 10 | Steris | 21.56 Bn | 21.12 Bn | 697.10 Mn | 15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50% |
| Dec 31, 2025 | 123.56% |
| Sep 30, 2025 | 60.13% |
| Jun 30, 2025 | 49.50% |
| Mar 31, 2025 | -56.76% |
| Dec 31, 2024 | 23.70% |
| Sep 30, 2024 | -11.28% |
| Jun 30, 2024 | -37.88% |
| Mar 31, 2024 | -35.35% |
| Dec 31, 2023 | -3.34% |
| Sep 30, 2023 | -7.46% |
| Jun 30, 2023 | -33.11% |
| Mar 31, 2023 | 2.76% |
| Dec 31, 2022 | -27.62% |
| Sep 30, 2022 | -34.96% |
| Jun 30, 2022 | -40.02% |
| Mar 31, 2022 | -162.12% |
| Dec 31, 2021 | -17.67% |
| Sep 30, 2021 | -0.69% |
| Jun 30, 2021 | 37.10% |